Platform

  • Search
  • Seminars
  • Conferences
  • Jobs

Resources

  • Submit Content
  • About Us

© 2025 World Wide

Open knowledge for all • Started with World Wide Neuro • A 501(c)(3) Non-Profit Organization

Analytics consent required

World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.

Review the Privacy Policy for details about analytics processing.

World Wide
SeminarsConferencesWorkshopsCoursesJobsMapsFeedLibrary
Back to SeminarsBack
SeminarPast EventNeuroscience

Radiopharmaceutical evaluation of novel bifunctional chelators and bioconjugates for tumour imaging and therapy

Manja Kubeil

Dr

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany

Schedule
Wednesday, October 12, 2022

Showing your local timezone

Schedule

Thursday, October 13, 2022

7:30 AM Australia/Melbourne

Host: Ad hoc

Access Seminar

Event Information

Domain

Neuroscience

Original Event

View source

Host

Ad hoc

Duration

70 minutes

Abstract

Bispidines (3,7-diazabicyclo[3.3.1]nonane) and their derivatives act as bifunctional chelators (BFC), combining the advantages of multidentate macrocyclic and acyclic ligands e.g. high kinetic inertness, rapid radiolabelling under mild conditions. This bicyclic chelator system shows a great diversity in terms of its denticity and type of functional groups, yielding a wide range of multidentate ligands that can bind a variety of different metal ions. In addition, they allow a facile functionalisation of targeting molecules such as peptides, peptidomimetics, and bispeci􀄀c antibodies. Herein, examples of various bispidine complexes labelled with [64Cu]Cu2+, [111In]In3+, [ 177Lu]Lu3+ or [ 225Ac]Ac3+ will be presented which provide a picture of how different substituents in􀄁uence the coordination mode. Target-speci􀄀c radiolabelled bispidine-based conjugates (e.g. peptides, antibody fragments, antibodies) investigated in vivo by positron emission or single-photon emission computed tomography will be presented and discussed in terms of their suitability for nuclear medicine applications.

Topics

[111In]In3+[177Lu]Lu3+[64Cu]Cu2+bifunctional chelatorsbispidinesmetal ionsradiolabelled conjugatesradiopharmaceuticalstumor imagingtumour imaging

About the Speaker

Manja Kubeil

Dr

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany

Contact & Resources

No additional contact information available

Related Seminars

Seminar60%

Pancreatic Opioids Regulate Ingestive and Metabolic Phenotypes

neuro

Jan 12, 2025
Washington University in St. Louis
Seminar60%

Exploration and Exploitation in Human Joint Decisions

neuro

Jan 12, 2025
Munich
Seminar60%

The Role of GPCR Family Mrgprs in Itch, Pain, and Innate Immunity

neuro

Jan 12, 2025
Johns Hopkins University
January 2026
Full calendar →